Bradley J. Ridder

Assessment of an <i>In Silico</i> Mechanistic Model for Proarrhythmia Risk Prediction Under the Ci<scp>PA</scp> Initiative

Zhihua Li, Bradley J. Ridder, Xiaomei Han et al. · Clinical Pharmacology & Therapeutics · 2018 · 179 citations · Full text

Medicine, Cardiology, Pharmacology +12

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy

Zhihua Li, Gary R. Mirams, Takashi Yoshinaga et al. · Clinical Pharmacology & Therapeutics · 2019 · 116 citations · Full text

Pharmacy, Cardiology, Pharmacology +9

Population Balance Model-Based Multiobjective Optimization of a Multisegment Multiaddition (MSMA) Continuous Plug-Flow Antisolvent Crystallizer

Bradley J. Ridder, Aniruddha Majumder, Zoltán K. Nagy · Industrial & Engineering Chemistry Research · 2014 · 62 citations

Engineering, Chemical Engineering, Pharmaceutics +13

A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm

Bradley J. Ridder, Derek J. Leishman, Matthew Bridgland‐Taylor et al. · Toxicology and Applied Pharmacology · 2020 · 48 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA model

Xiaomei Han, Mohammadreza Samieegohar, Bradley J. Ridder et al. · Journal of Pharmacological and Toxicological Methods · 2020 · 19 citations · Full text

Pharmacy, Cardiology, Pharmacology +16